| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 20 |
| 1 | NIVOLUMAB | 15 |
| 2 | PEMETREXED DISODIUM | 10 |
| 3 | PACLITAXEL | 9 |
| 4 | DURVALUMAB | 5 |
| 5 | PEMETREXED | 5 |
| 6 | BRIGATINIB | 4 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 8 | FUROSEMIDE | 4 |
| 9 | MAGNESIUM OXIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | BRIGATINIB | 4 | 0.0011 |
| 2 | DANTROLENE SODIUM | 1 | 0.0009 |
| 3 | SOTORASIB | 3 | 0.0009 |
| 4 | TREMELIMUMAB | 3 | 0.0007 |
| 5 | NALDEMEDINE | 1 | 0.0006 |
| 6 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 7 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 8 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 9 | ALECTINIB HYDROCHLORIDE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 54 | 0.0005 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 5 | 0.0002 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 6 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 7 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 8 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |